ESLOF
Price
$292.78
Change
+$0.60 (+0.21%)
Updated
Aug 8 closing price
Capitalization
136.16B
TRUMY
Price
$18.60
Change
-$0.07 (-0.37%)
Updated
Aug 8 closing price
Capitalization
27.47B
87 days until earnings call
Interact to see
Advertisement

ESLOF vs TRUMY

Header iconESLOF vs TRUMY Comparison
Open Charts ESLOF vs TRUMYBanner chart's image
EssilorLuxottica
Price$292.78
Change+$0.60 (+0.21%)
Volume$486
Capitalization136.16B
Terumo
Price$18.60
Change-$0.07 (-0.37%)
Volume$158.26K
Capitalization27.47B
ESLOF vs TRUMY Comparison Chart in %
Loading...
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOF vs. TRUMY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOF is a Hold and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (ESLOF: $292.78 vs. TRUMY: $18.60)
Brand notoriety: ESLOF and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOF: 66% vs. TRUMY: 61%
Market capitalization -- ESLOF: $136.16B vs. TRUMY: $27.47B
ESLOF [@Pharmaceuticals: Other] is valued at $136.16B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $27.47B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOF’s FA Score shows that 3 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • ESLOF’s FA Score: 3 green, 2 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, ESLOF is a better buy in the long-term than TRUMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOF’s TA Score shows that 4 TA indicator(s) are bullish while TRUMY’s TA Score has 4 bullish TA indicator(s).

  • ESLOF’s TA Score: 4 bullish, 4 bearish.
  • TRUMY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ESLOF is a better buy in the short-term than TRUMY.

Price Growth

ESLOF (@Pharmaceuticals: Other) experienced а -1.94% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was +9.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOF($136B) has a higher market cap than TRUMY($27.5B). ESLOF has higher P/E ratio than TRUMY: ESLOF (48.75) vs TRUMY (34.66). ESLOF YTD gains are higher at: 21.865 vs. TRUMY (-4.615). TRUMY has higher annual earnings (EBITDA): 247B vs. ESLOF (6.71B). TRUMY has more cash in the bank: 195B vs. ESLOF (3.16B). ESLOF has less debt than TRUMY: ESLOF (14B) vs TRUMY (175B). TRUMY has higher revenues than ESLOF: TRUMY (987B) vs ESLOF (27.2B).
ESLOFTRUMYESLOF / TRUMY
Capitalization136B27.5B495%
EBITDA6.71B247B3%
Gain YTD21.865-4.615-474%
P/E Ratio48.7534.66141%
Revenue27.2B987B3%
Total Cash3.16B195B2%
Total Debt14B175B8%
FUNDAMENTALS RATINGS
ESLOF vs TRUMY: Fundamental Ratings
ESLOF
TRUMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
38
Fair valued
PROFIT vs RISK RATING
1..100
2197
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
5051
P/E GROWTH RATING
1..100
3240
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOF's Valuation (32) in the null industry is in the same range as TRUMY (38). This means that ESLOF’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOF's Profit vs Risk Rating (21) in the null industry is significantly better than the same rating for TRUMY (97). This means that ESLOF’s stock grew significantly faster than TRUMY’s over the last 12 months.

ESLOF's SMR Rating (95) in the null industry is in the same range as TRUMY (99). This means that ESLOF’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOF's Price Growth Rating (50) in the null industry is in the same range as TRUMY (51). This means that ESLOF’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOF's P/E Growth Rating (32) in the null industry is in the same range as TRUMY (40). This means that ESLOF’s stock grew similarly to TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOFTRUMY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bearish Trend 4 days ago
63%
Bullish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
55%
Bearish Trend 12 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
58%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGHC10.720.34
+3.28%
Super Group (SGHC) Limited
SLND4.530.06
+1.34%
Southland Holdings
BHLB24.350.31
+1.29%
Berkshire Hills Bancorp
ICE186.40-1.62
-0.86%
Intercontinental Exchange
KLTO0.90-0.04
-3.99%
Klotho Neurosciences Inc

ESLOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOF has been loosely correlated with ESLOY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOF jumps, then ESLOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOF
1D Price
Change %
ESLOF100%
+0.21%
ESLOY - ESLOF
58%
Loosely correlated
+0.39%
SAUHF - ESLOF
37%
Loosely correlated
-5.99%
SMMNY - ESLOF
33%
Loosely correlated
+0.82%
WILYY - ESLOF
21%
Poorly correlated
N/A
TRUMY - ESLOF
21%
Poorly correlated
-0.37%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.37%
HOCPY - TRUMY
51%
Loosely correlated
+4.52%
SSMXY - TRUMY
46%
Loosely correlated
+0.80%
OLYMY - TRUMY
44%
Loosely correlated
-1.32%
GNNDY - TRUMY
33%
Poorly correlated
+4.33%
ESLOY - TRUMY
30%
Poorly correlated
+0.39%
More